Clinical trials begin for flu vaccine-coated Vaxxas patches
Brisbane-based vaccine delivery technology Vaxxas has announced initiation of a Phase 1 clinical trial for flu shots administered by the company’s high-density microarray patch (HD-MAP.) According to a statement from the company on Friday, the trial will take place at three University of the Sunshine Coast’s clinical research sites – in Brisbane, Morayfield and Sippy…